Literature DB >> 30232600

Human Organotypic Models for Anti-infective Research.

Astrid Hendriks1,2, Ana Rita Cruz1,2, Elisabetta Soldaini1, Andrea Guido Oreste Manetti1, Fabio Bagnoli3.   

Abstract

The use of human organotypic models for biomedical research is experiencing a significant increase due to their biological relevance, the possibility to perform high-throughput analyses, and their cost efficiency. In the field of anti-infective research, comprising the search for novel antipathogenic treatments including vaccines, efforts have been made to reduce the use of animal models. That is due to two main reasons: unreliability of data obtained with animal models and the increasing willingness to reduce the use of animals in research for ethical reasons. Human three-dimensional (3-D) models may substitute and/or complement in vivo studies, to increase the translational value of preclinical data. Here, we provide an overview of recent studies utilizing human organotypic models, resembling features of the cervix, intestine, lungs, brain, and skin in the context of anti-infective research. Furthermore, we focus on the future applications of human skin models and present methodological protocols to culture human skin equivalents and human skin explants.

Entities:  

Year:  2021        PMID: 30232600     DOI: 10.1007/82_2018_130

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  81 in total

1.  A new organotypic model containing dermal-type macrophages.

Authors:  Nicolas Bechetoille; Hortense Vachon; Amandine Gaydon; Aurelie Boher; Thomas Fontaine; Evelyne Schaeffer; Marion Decossas; Valérie André-Frei; Christopher G Mueller
Journal:  Exp Dermatol       Date:  2011-11-02       Impact factor: 3.960

2.  Structure and function of the epidermis related to barrier properties.

Authors:  Adone Baroni; Elisabetta Buommino; Vincenza De Gregorio; Eleonora Ruocco; Vincenzo Ruocco; Ronni Wolf
Journal:  Clin Dermatol       Date:  2012 May-Jun       Impact factor: 3.541

3.  Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication.

Authors:  Graciela Andrei; Andrea Lisco; Christophe Vanpouille; Andrea Introini; Emanuela Balestra; Joost van den Oord; Tomas Cihlar; Carlo-Federico Perno; Robert Snoeck; Leonid Margolis; Jan Balzarini
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

4.  A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection.

Authors:  Sheila R Abner; Patricia C Guenthner; Jeannette Guarner; Kelly A Hancock; James E Cummins; Aaron Fink; G Thomas Gilmore; Charles Staley; Albert Ward; Odessa Ali; Sander Binderow; Stephen Cohen; Lisa A Grohskopf; Lynn Paxton; Clyde E Hart; Charlene S Dezzutti
Journal:  J Infect Dis       Date:  2005-09-26       Impact factor: 5.226

5.  A critical role of T follicular helper cells in human mucosal anti-influenza response that can be enhanced by immunological adjuvant CpG-DNA.

Authors:  A N Aljurayyan; R Sharma; N Upile; H Beer; C Vaughan; C Xie; P Achar; M S Ahmed; P S McNamara; S B Gordon; Q Zhang
Journal:  Antiviral Res       Date:  2016-05-28       Impact factor: 5.970

6.  Organotypic epithelial raft cultures as a model for evaluating compounds against alphaherpesviruses.

Authors:  Graciela Andrei; Joost van den Oord; Pierre Fiten; Ghislain Opdenakker; Chris De Wolf-Peeters; Erik De Clercq; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

7.  Activity and therapeutic potential of ORI-1001 antisense oligonucleotide on human papillomavirus replication utilizing a model of dysplastic human epithelium.

Authors:  Samina Alam; Jennifer Bromberg-White; Margaret McLaughlin-Drubin; Ellora Sen; Jason M Bodily; Craig Meyers
Journal:  Anticancer Res       Date:  2005 Mar-Apr       Impact factor: 2.480

8.  Effects of solar ultraviolet radiation on engineered human skin equivalent containing both Langerhans cells and dermal dendritic cells.

Authors:  Nicolas Bechetoille; Colette Dezutter-Dambuyant; Odile Damour; Valérie André; Isabelle Orly; Eric Perrier
Journal:  Tissue Eng       Date:  2007-11

9.  Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.

Authors:  Jared M Baeten; Lara B Strick; Aldo Lucchetti; William L H Whittington; Jorge Sanchez; Robert W Coombs; Amalia Magaret; Anna Wald; Lawrence Corey; Connie Celum
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

10.  A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.

Authors:  Jan Balzarini; Graciela Andrei; Emanuela Balestra; Dana Huskens; Christophe Vanpouille; Andrea Introini; Sonia Zicari; Sandra Liekens; Robert Snoeck; Antonín Holý; Carlo-Federico Perno; Leonid Margolis; Dominique Schols
Journal:  PLoS Pathog       Date:  2013-07-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.